7.46
price up icon1.36%   0.10
after-market アフターアワーズ: 7.38 -0.08 -1.07%
loading
前日終値:
$7.36
開ける:
$7.4
24時間の取引高:
291.59K
Relative Volume:
0.26
時価総額:
$211.97M
収益:
$157.75M
当期純損益:
$-29.73M
株価収益率:
-6.431
EPS:
-1.16
ネットキャッシュフロー:
$-21.00M
1週間 パフォーマンス:
+5.07%
1か月 パフォーマンス:
+21.10%
6か月 パフォーマンス:
-50.07%
1年 パフォーマンス:
-54.76%
1日の値動き範囲:
Value
$7.3303
$7.59
1週間の範囲:
Value
$7.00
$7.89
52週間の値動き範囲:
Value
$5.85
$24.17

Arcturus Therapeutics Holdings Inc Stock (ARCT) Company Profile

Name
名前
Arcturus Therapeutics Holdings Inc
Name
セクター
Healthcare (1113)
Name
電話
(858) 900-2660
Name
住所
10285 SCIENCE CENTER DRIVE, SAN DIEGO, CA
Name
職員
176
Name
Twitter
@ArcturusRx
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
ARCT's Discussions on Twitter

ARCT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ARCT
Arcturus Therapeutics Holdings Inc
7.46 209.13M 157.75M -29.73M -21.00M -1.16
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.17 120.98B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
771.25 80.15B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ARGX
Argen X Se Adr
864.42 51.56B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
354.75 47.74B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ONC
Beone Medicines Ltd Adr
336.16 37.38B 4.98B 69.59M 525.67M 0.5197

Arcturus Therapeutics Holdings Inc Stock (ARCT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-01-23 開始されました Roth Capital Buy
2025-10-24 ダウングレード H.C. Wainwright Buy → Neutral
2025-10-23 ダウングレード Citigroup Buy → Neutral
2025-10-22 ダウングレード Guggenheim Buy → Neutral
2025-09-04 再開されました H.C. Wainwright Buy
2025-05-28 開始されました Scotiabank Sector Outperform
2025-01-28 開始されました BTIG Research Buy
2024-08-12 開始されました Leerink Partners Outperform
2023-12-13 開始されました Canaccord Genuity Buy
2023-07-24 開始されました William Blair Outperform
2023-05-11 アップグレード H.C. Wainwright Neutral → Buy
2022-11-14 再開されました Wells Fargo Overweight
2022-11-10 ダウングレード Robert W. Baird Neutral → Underperform
2022-11-03 アップグレード Citigroup Neutral → Buy
2022-11-02 アップグレード Barclays Underweight → Equal Weight
2022-08-10 ダウングレード Raymond James Mkt Perform → Underperform
2022-07-19 再開されました Cantor Fitzgerald Overweight
2022-05-11 アップグレード Robert W. Baird Underperform → Neutral
2022-04-21 ダウングレード Citigroup Buy → Neutral
2022-01-31 アップグレード Raymond James Underperform → Mkt Perform
2021-08-12 ダウングレード Raymond James Mkt Perform → Underperform
2021-08-11 ダウングレード Goldman Neutral → Sell
2021-08-10 ダウングレード Robert W. Baird Neutral → Underperform
2021-07-02 開始されました Cantor Fitzgerald Overweight
2021-06-25 再開されました Goldman Neutral
2021-06-21 ダウングレード Barclays Equal Weight → Underweight
2021-06-04 再開されました Robert W. Baird Neutral
2021-02-17 ダウングレード B. Riley Securities Neutral → Sell
2021-01-19 ダウングレード B. Riley Securities Buy → Neutral
2021-01-15 ダウングレード B. Riley Securities Buy → Neutral
2021-01-07 開始されました Wells Fargo Overweight
2020-12-29 ダウングレード Barclays Overweight → Equal Weight
2020-12-29 ダウングレード H.C. Wainwright Buy → Neutral
2020-12-29 ダウングレード Raymond James Outperform → Mkt Perform
2020-12-29 ダウングレード Robert W. Baird Outperform → Neutral
2020-12-23 ダウングレード ROTH Capital Buy → Sell
2020-12-08 繰り返されました B. Riley Securities Buy
2020-12-07 繰り返されました B. Riley Securities Buy
2020-10-26 開始されました Barclays Overweight
2020-10-06 開始されました Citigroup Buy
2020-08-26 開始されました Piper Sandler Overweight
2020-07-30 再開されました ROTH Capital Buy
2020-07-16 開始されました Raymond James Outperform
2020-07-13 開始されました B. Riley FBR Buy
2020-06-09 ダウングレード WBB Securities Buy → Hold
2020-02-11 開始されました Robert W. Baird Outperform
2020-02-07 開始されました Guggenheim Buy
2020-02-06 開始されました Guggenheim Buy
2019-04-05 開始されました H.C. Wainwright Buy
2018-09-20 アップグレード WBB Securities Buy → Strong Buy
2018-01-22 開始されました Chardan Capital Markets Buy
すべてを表示

Arcturus Therapeutics Holdings Inc (ARCT) 最新ニュース

pulisher
Jan 24, 2026

Arcturus Therapeutics (NASDAQ:ARCT) Stock Rating Upgraded by Roth Mkm - MarketBeat

Jan 24, 2026
pulisher
Jan 24, 2026

Roth/MKM initiates coverage on Arcturus Therapeutics stock with Buy rating By Investing.com - Investing.com India

Jan 24, 2026
pulisher
Jan 23, 2026

Stifel Initiates Arcturus Therapeutics(ARCT.US) With Buy Rating, Announces Target Price $20 - 富途资讯

Jan 23, 2026
pulisher
Jan 23, 2026

Roth/MKM initiates coverage on Arcturus Therapeutics stock with Buy rating - Investing.com

Jan 23, 2026
pulisher
Jan 19, 2026

Arcturus wins FDA fast track status for influenza vaccine - MSN

Jan 19, 2026
pulisher
Jan 17, 2026

Price-Driven Insight from (ARCT) for Rule-Based Strategy - Stock Traders Daily

Jan 17, 2026
pulisher
Jan 15, 2026

Market Review: How liquid is Arcturus Therapeutics Holdings Inc stockJuly 2025 Summary & Growth Focused Entry Point Reports - baoquankhu1.vn

Jan 15, 2026
pulisher
Jan 15, 2026

Analysis Recap: Should value investors consider Arcturus Therapeutics Holdings Inc2025 Valuation Update & Fast Moving Market Watchlists - baoquankhu1.vn

Jan 15, 2026
pulisher
Jan 15, 2026

Aug EndMonth: Should value investors consider Arcturus Therapeutics Holdings Inc2025 Market Overview & Risk Controlled Swing Alerts - baoquankhu1.vn

Jan 15, 2026
pulisher
Jan 14, 2026

FEDERATED HERMES, INC. Reduces Stake in Arcturus Therapeutics Ho - GuruFocus

Jan 14, 2026
pulisher
Jan 14, 2026

Does Arcturus Therapeutics (ARCT) JPM Conference Spotlight Clarify Its Long-Term Platform Credibility? - simplywall.st

Jan 14, 2026
pulisher
Jan 13, 2026

Aug EndMonth: Should I hold or sell Arcturus Therapeutics Holdings Inc stock in 2025July 2025 Update & AI Powered Buy and Sell Recommendations - Bộ Nội Vụ

Jan 13, 2026
pulisher
Jan 13, 2026

Arcturus Therapeutics Holdings (ARCT) Valuation Check As J.P. Morgan Healthcare Conference Presentation Nears - Yahoo Finance

Jan 13, 2026
pulisher
Jan 12, 2026

Arcturus Therapeutics Maps Near-Term Milestones for CF mRNA Therapy, ARCT-810 at J.P. Morgan Conference - MarketBeat

Jan 12, 2026
pulisher
Jan 12, 2026

ARCT: Advancing mRNA therapies for CF and OTC with strong data, regulatory focus, and solid funding - TradingView

Jan 12, 2026
pulisher
Jan 12, 2026

Is Arcturus Therapeutics (ARCT) Using Its $500 Million Shelf to Redefine Capital Strategy? - Yahoo Finance

Jan 12, 2026
pulisher
Jan 10, 2026

Ag Plus, Inc. - Ag Plus, Inc.

Jan 10, 2026
pulisher
Jan 10, 2026

1 Under-$10 Stock Set to Surge as Much as 963% in 2026 - Yahoo Finance

Jan 10, 2026
pulisher
Jan 10, 2026

Will Arcturus Therapeutics Holdings Inc. stock maintain momentum in 2025Portfolio Profit Report & AI Driven Stock Movement Reports - ulpravda.ru

Jan 10, 2026
pulisher
Jan 10, 2026

Arcturus Gets FDA's Fast Track Tag for Influenza Vaccine Candidate - MSN

Jan 10, 2026
pulisher
Jan 09, 2026

Arcturus Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - BioSpace

Jan 09, 2026
pulisher
Jan 08, 2026

Can Arcturus Therapeutics Holdings Inc. stock rebound after recent weaknessPortfolio Profit Report & Precise Entry and Exit Recommendations - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Is Arcturus Therapeutics Holdings Inc. stock positioned well for digital economyJuly 2025 Selloffs & Scalable Portfolio Growth Ideas - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Earnings Beat: Can Arcturus Therapeutics Holdings Inc. stock rebound after recent weaknessWeekly Earnings Recap & Real-Time Volume Surge Alerts - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Arcturus Therapeutics Holdings (ARCT): Analyst Ratings Suggest a Staggering 415% Upside Potential - DirectorsTalk Interviews

Jan 08, 2026
pulisher
Jan 06, 2026

Citigroup Lowers Price Target for ARCT, Maintains Neutral Rating - GuruFocus

Jan 06, 2026
pulisher
Jan 06, 2026

(ARCT) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily

Jan 06, 2026
pulisher
Jan 06, 2026

Arcturus Therapeutics (NASDAQ:ARCT) Price Target Cut to $7.00 by Analysts at Citigroup - MarketBeat

Jan 06, 2026
pulisher
Jan 04, 2026

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Jan 04, 2026
pulisher
Jan 02, 2026

UK Regulator OKs Arcturus Therapeutics' COVID-19 Booster Jab - MarketScreener

Jan 02, 2026
pulisher
Jan 02, 2026

MHRA approves Kostaive mRNA COVID-19 vaccine - The Pharma Letter

Jan 02, 2026
pulisher
Jan 01, 2026

What analysts say about Arcturus Therapeutics Holdings Inc stockStraddle and Strangle Trades & Investment Case Studies - earlytimes.in

Jan 01, 2026
pulisher
Dec 31, 2025

Arcturus Therapeutics (NASDAQ:ARCT) Share Price Passes Below Two Hundred Day Moving AverageTime to Sell? - MarketBeat

Dec 31, 2025
pulisher
Dec 30, 2025

Arcturus Therapeutics Holdings files for mixed shelf of up to $500 millionSEC filing - MarketScreener

Dec 30, 2025
pulisher
Dec 30, 2025

Arcturus Therapeutics Files $500 Million Mixed Shelf - MarketScreener

Dec 30, 2025
pulisher
Dec 26, 2025

Precision Trading with Arcturus Therapeutics Holdings Inc. (ARCT) Risk Zones - Stock Traders Daily

Dec 26, 2025
pulisher
Dec 25, 2025

Arcturus Therapeutics (ARCT) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 25, 2025
pulisher
Dec 25, 2025

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: Unveiling A 446% Potential Upside - directorstalkinterviews.com

Dec 25, 2025
pulisher
Dec 21, 2025

Arcturus Therapeutics Holdings Inc.(NasdaqGM:ARCT) dropped from S&P Biotechnology Select Industry Index - marketscreener.com

Dec 21, 2025
pulisher
Dec 20, 2025

Will Arcturus Therapeutics Holdings Inc. stock benefit from infrastructure spending2025 Volume Leaders & Risk Controlled Daily Trade Plans - Улправда

Dec 20, 2025
pulisher
Dec 19, 2025

How strong is Arcturus Therapeutics Holdings Inc. stock balance sheetMarket Activity Report & Weekly Watchlist of Top Performers - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

How Arcturus Therapeutics Holdings Inc. stock reacts to job market dataTrade Risk Assessment & Weekly High Return Stock Forecasts - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Why Arcturus Therapeutics Holdings Inc. stock could outperform in 2025Weekly Market Report & Daily Momentum Trading Reports - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

How supply chain issues affect Arcturus Therapeutics Holdings Inc. stockWeekly Trend Recap & AI Enhanced Market Trend Forecasts - DonanımHaber

Dec 19, 2025
pulisher
Dec 15, 2025

Arcturus Therapeutics Holdings Inc. Announces Management Changes - marketscreener.com

Dec 15, 2025
pulisher
Dec 15, 2025

Arcturus Therapeutics CFO Andy Sassine to leave company - marketscreener.com

Dec 15, 2025
pulisher
Dec 15, 2025

Arcturus Therapeutics announces CFO transition and interim appointment By Investing.com - Investing.com Australia

Dec 15, 2025
pulisher
Dec 15, 2025

Arcturus Therapeutics Announces CFO Departure and Replacement - TipRanks

Dec 15, 2025
pulisher
Dec 15, 2025

Arcturus Therapeutics announces CFO departure and replacement - MSN

Dec 15, 2025
pulisher
Dec 15, 2025

Arcturus Therapeutics announces CFO transition and interim appointment - Investing.com

Dec 15, 2025
pulisher
Dec 15, 2025

Arcturus Therapeutics Announces CFO Departure and Interim Appointment - TradingView — Track All Markets

Dec 15, 2025

Arcturus Therapeutics Holdings Inc (ARCT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$99.82
price up icon 2.09%
$103.47
price up icon 0.87%
$34.40
price up icon 2.78%
$119.34
price up icon 1.14%
$162.64
price up icon 1.83%
biotechnology ONC
$336.16
price down icon 0.48%
大文字化:     |  ボリューム (24 時間):